RhoA-mediated regulation of myosin-II activity in the actin cortex controls the ability of cells to contract and bleb during a variety of cellular processes, including cell migration and division. Cell contraction and blebbing also frequently occur as part of the cytopathic effect seen during many different viral infections. We now demonstrate that the vaccinia virus protein F11, which localizes to the plasma membrane, is required for ROCK-mediated cell contraction from 2 hr post infection. Curiously, F11-induced cell contraction is dependent on RhoC and not RhoA signaling to ROCK. Moreover, RhoC-driven cell contraction depends on the upstream inhibition of RhoD signaling by F11. This inhibition prevents RhoD from regulating its downstream effector Pak6, alleviating the suppression of RhoC by the kinase. Our observations with vaccinia have now demonstrated that RhoD recruits Pak6 to the plasma membrane to antagonize RhoC signaling during cell contraction and blebbing.
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Many different viral infections induce cell contraction and blebbing. Durkin, Leite, et al. show that during vaccinia infection, RhoC and not RhoA regulates this ROCKmediated cytopathic effect of cell contraction. They delineate a pathway for RhoC regulation, in which the viral protein F11 blocks RhoC antagonism by RhoDrecruited Pak6.
INTRODUCTION
The cortical actin cytoskeleton consists of a dense network of actin filaments, crosslinked by myosin-II and other actin-binding proteins, that is intrinsically linked to the cytoplasmic face of the plasma membrane (Biro et al., 2013; Charras et al., 2006; Clark et al., 2013; Fritzsche et al., 2013; Koster and Mayor, 2016; Morone et al., 2006) . The regulation of the density and organization of actin filaments in the cell cortex, as well as their myosin-II driven contraction, provides the cell with mechanical resilience (Bovellan et al., 2014; Clark et al., 2013; Fritzsche et al., 2013 Fritzsche et al., , 2016 Gauthier et al., 2012; Salbreux et al., 2012; Tinevez et al., 2009) . It also enables the cortical actin cytoskeleton to regulate the shape of the cell during a variety of cellular processes including migration, mitotic rounding, and cytokinesis (Friedl and Wolf, 2003; Matthews et al., 2012; Sedzinski et al., 2011; Zatulovskiy et al., 2014) . A frequent hallmark of myosin-II-driven contraction of the actin cortex during these cellular processes is the transient and rapid appearance of spherical blebs on the plasma membrane . These protrusions occur at regions where the plasma membrane separates from the underlying actin cortex because of increased hydrostatic pressure within the cell Paluch et al., 2006; Tinevez et al., 2009) .
Over the last decade, it has become clear that blebbing of the plasma membrane helps drive ameboid-based cell motility during development and tumor cell migration (Blaser et al., 2006; Charras and Paluch, 2008; Diz-Munoz et al., 2010; Fackler and Grosse, 2008; Friedl and Wolf, 2003; Kardash et al., 2010; Paluch and Raz, 2013; Sahai and Marshall, 2003; Sanz-Moreno et al., 2008; Tozluoglu et al., 2013) . A key determinant for assembly and contraction of the actin cortex is the activation of myosin-II by ROCK-mediated phosphorylation of the myosin light chain (MLC) (Amano et al., 1997 (Amano et al., , 1996 (Amano et al., , 2010 Amin et al., 2013; Sahai and Marshall, 2003) . ROCK also indirectly increases the activity of myosin-II by inhibiting the MLC phosphatase through phosphorylation of the myosin phosphatase-targeting subunit 1 (MYPT1) (Amano et al., 2010; Amin et al., 2013; Kawano et al., 1999) . The small guanosine triphosphatase (GTPase) RhoA is most widely implicated in activating ROCK to drive cell contraction (Charras et al., 2006; Costigliola et al., 2010; Gutjahr et al., 2005; Sahai and Marshall, 2003; Sanz-Moreno et al., 2008) . However, ROCK can also interact with the closely related GTPase RhoC, which is known to promote ameboid-based motility, tumor invasion, and metastasis (Clark et al., 2000; Hakem et al., 2005; Kitzing et al., 2010; Leung et al., 1996; Ruth et al., 2006; Sahai and Marshall, 2002; Simpson et al., 2004) .
Cell contraction and membrane blebbing are also frequently observed as part of the cytopathic effect induced by many different viruses during their replication cycles (Agol, 2012) . For example, within a few hours of vaccinia virus infection, cells begin to contract and bleb, in a process that is independent of (legend continued on next page) apoptosis (Bablanian et al., 1978; Barry et al., 2015; Schepis et al., 2006; Schramm et al., 2006) . Previous observations suggest the vaccinia protein F11, which is expressed early in infection, is involved in vaccinia-induced cell contraction and/or the loss of cell-cell adhesion Morales et al., 2008; Valderrama et al., 2006) . F11 downregulates RhoA signaling in the latter stages of the virus replication cycle (Arakawa et al., 2007b; Cordeiro et al., 2009; Valderrama et al., 2006) . F11 binds directly to GTP-bound RhoA using a motif that is conserved in ROCK Valderrama et al., 2006) . Once bound, RhoA is inactivated by the Rho GTPase-activating protein (RhoGAP) activity of myosin-9A, which binds to the central PDZ-like domain of F11 via its C-terminal PDZ-binding motif . Ultimately, F11-mediated inhibition of RhoA signaling late during viral replication promotes the spread of vaccinia infection by stimulating cell migration, increasing microtubule dynamics, and enhancing viral release by modulating the cortical actin beneath the plasma membrane (Arakawa et al., 2007a (Arakawa et al., , 2007b Cordeiro et al., 2009; Handa et al., 2013; Valderrama et al., 2006) . Consistent with its role during vaccinia virus infection, ectopic expression of F11 can enhance the cell-to-cell spread and oncolytic potential of myxoma virus, which lacks F11 (Irwin and Evans, 2012; Irwin et al., 2013) . Previous studies on F11 have largely focused on its role in infected cells at 8-20 hr post infection (hpi) (Arakawa et al., 2007a (Arakawa et al., , 2007b Cordeiro et al., 2009; Handa et al., 2013; Valderrama et al., 2006) . However, F11 expression correlates with the onset of virus-induced cell contraction Morales et al., 2008) . With this in mind, we set out to investigate whether and how F11 plays a role in vaccinia-induced cell contraction and blebbing. We found that vaccinia stimulates cell contraction independently of RhoA by activating RhoC-mediated signaling to ROCK. Furthermore, the ability of RhoC to promote this effect depends on F11-mediated inhibition of RhoD signaling to Pak6.
RESULTS

F11 Induces Cell Contraction Early during Vaccinia Infection
In agreement with earlier studies, live-cell imaging demonstrates that within the first few hours of infection the Western Reserve (WR) strain of vaccinia induces contraction and blebbing of HeLa cells (Figures 1A and 1B ; Movie S1). Quantification of the cell area reveals that maximum contraction and blebbing occurs approximately 3 hr 40 min post infection, after which time infected cells begin to respread ( Figures 1C and 1D ). Vacciniainduced cell contraction is not specific to HeLa cells, as it is also seen in U-2 OS cells ( Figure S1A ). In contrast, infection with WR lacking the F11L gene (DF11L virus) does not induce cells to contract or bleb ( Figures 1A, 1C , and S1A). In agreement with Schepis et al. (2006) , we also found that the highly attenuated virus strain, Modified Vaccinia Ankara (MVA), which does not express a functional F11, did not induce HeLa cell contraction early during infection ( Figure S1B ). Using a recombinant virus expressing GFP-tagged F11 from its endogenous promoter, we found that F11 associates with the plasma membrane, consistent with a possible role in regulating the actin cortex (Figure 1E and Movie S2) . Immunoblot analysis of WR-infected cells confirmed that the onset of cell contraction correlates with the expression of F11 ( Figure 1F ). Moreover, respreading correlates with a gradual loss of F11, suggesting that its presence promotes vaccinia-induced cell contraction. Consistent with this, prolonged expression of F11 in U-2 OS cells suppresses their respreading at later time points ( Figure S1A) . A role for F11 in promoting cell contraction is unexpected, given previous observations demonstrating that the viral protein inhibits, rather than activates, RhoA signaling.
Vaccinia-Induced Cell Contraction Depends on ROCK
It is well established that RhoA signaling to ROCK promotes myosin-II-mediated cell contraction and blebbing by phosphorylating MLC and also inhibiting MYPT1 (Amin et al., 2013; Julian and Olson, 2014) . To investigate whether ROCK is also required for vaccinia-induced cell contraction, we infected cells in the presence of one of three different ROCK inhibitors. In all cases, we found that there was a dramatic inhibition in virus-induced cell contraction, consistent with the reduction in MLC2 and MYPT1 phosphorylation seen in immunoblots (Figures 2A and  S2A ). Lack of cell contraction was not due to an inhibition of viral entry, as the drug treated cells were equally as well infected as control cells ( Figure S2B ). To extend our pharmacological analysis, we examined the impact of small interfering RNA (siRNA)-mediated depletion of ROCK1 and ROCK2 on virus-induced cell contraction. Independent knockdown of either kinase did not significantly impair cell contraction ( Figures 2B and S2C ). When both proteins were depleted, early viral protein expression was not impaired but there was a substantial inhibition of cell contraction ( Figures 2B and S2D ). To explore whether additional signaling pathways also contribute to myosin-II activation, we treated cells with siRNA against myotonic dystrophy kinaserelated Cdc42-binding kinases (MRCKa/b) and zipper-interacting protein kinase (ZIPK) (Nehru et al., 2013; Usui et al., 2014; Zhao and Manser, 2015) . We found that WR-infected cells still contract in the absence of MRCKa/b and ZIPK ( Figures 2C and  2D ). In addition, we treated infected cells with ML7 or ML9 to inhibit MLC kinase (MLCK) to examine whether it also participates in virus-driven cell contraction. Consistent with a role for myosin-II during viral entry (Mercer and Helenius, 2008) , we found that inhibition of MLCK with ML7 or ML9 dramatically reduced early viral protein expression ( Figure 2E ). To overcome this inhibition, we infected cells in the presence of cycloheximide to block viral uncoating (Mercer et al., 2012) , before adding ML7 or ML9 ( Figure 2F ). Removal of the cycloheximide in the presence of ML7 or ML9 restarts the stalled replication cycle, resulting in early viral protein expression and cell contraction ( Figure 2F ). Taken together, our results indicate that ROCKmediated regulation of myosin-II is required for vaccinia-induced cell contraction and that both isoforms are functionally redundant. The global levels of phospho-MLC did not appreciably change during WR or DF11L virus infection, but the subcellular distribution of phospho-MLC was strikingly different ( Figures S2A and S2E ). Live-cell imaging also reveals that RFP-MLC2 is recruited to the blebbing cell cortex (Figure S2F and Movie S3) , suggesting that localized ROCK activity drives the redistribution of myosin-II to promote cell contraction.
Vaccinia Promotes RhoC-but Not RhoA-Dependent Cell Contraction Given the involvement of ROCK1/2, we wondered whether an interaction of F11 with RhoA is also required for virus-induced cell contraction. To address this question, we infected cells with a recombinant virus expressing F11-VK, which is defective in RhoA binding . We found that the F11-VK virus is as effective as the parental WR strain in inducing cell contraction ( Figure 3A and Movie S1). Furthermore, siRNA-mediated depletion of RhoA did not impact on the ability of WR to induce cell contraction (Figure 3B) . In contrast, the Clostridium botulinum toxin C3, a panRhoA, B, and C inhibitor (Aktories, 2011) , blocked virus-induced cell contraction but not infection ( Figures 3C and S3 ). This suggests that vaccinia-induced cell contraction is independent of RhoA but reliant on the activation of ROCK by another RhoGTPase.
Previous studies have linked RhoB, RhoC, RhoD, RhoE, and RhoF (Rif) to ROCK signaling (Fan et al., 2010; Leung et al., 1996; Riento and Ridley, 2003; Tsubakimoto et al., 1999) . Given this finding, we examined whether F11 also interacts with these RhoGTPases. Pull-down assays on lysates from infected HeLa cells demonstrate that glutathione S-transferase (GST)-F11 associates with GFP-tagged RhoC, D, E, and F but not RhoB or Rac ( Figure 4A ). To examine whether any of these RhoGTPases are required for vaccinia-induced cell contraction, we performed siRNA-mediated ablation of each protein (Figures S4A and S4B) . We found that only depletion of RhoC had a significant impact on the ability of WR to induce cell contraction ( Figure 4B ). Consistent with the lack of involvement of RhoA, the combined loss of RhoA and RhoC did not result in a greater inhibition of WR-induced cell contraction than RhoC alone ( Figures 4B  and S4A ). In addition, expression of GFP-tagged dominant-nega- tive RhoC-T19N blocked WR-mediated cell contraction ( Figure 4C ). In contrast, expression of GFP-RhoC stimulated partial contraction of DF11L virus-infected cells ( Figure 4C ). In agreement with its role in promoting cell contraction, RhoC is associated with the plasma membrane of blebs ( Figure 4D and Movie S4). The involvement of RhoC explains why C3 toxin blocks WR-induced cell contraction ( Figure 3C ). Moreover, C3 treatment did not increase the suppression of cell contraction induced by the loss of RhoC ( Figure 4E ). To confirm that RhoC acts via ROCK to promote contraction of infected cells, we depleted both RhoC and ROCK1/2. Depletion of all three proteins impaired WR-induced cell contraction to the same extent as the loss of ROCK1/2 or RhoC alone ( Figure 4F ). Our observations demonstrate that vaccinia-induced cell contraction involves RhoC-mediated activation of ROCK.
F11-Mediated Inhibition of RhoD Promotes RhoC-Driven Cell Contraction
It is well established that RhoGTPases frequently regulate each other (Guilluy et al., 2011) . Given their interaction with F11, it is possible that RhoD, RhoE, and RhoF may have an inhibitory role in promoting vaccinia-induced cell contraction. We found that loss of RhoD but not RhoE or RhoF results in contraction of DF11L virus-infected cells (Figures 5A and S5A) . Moreover, this contraction has temporal dynamics similar to those of WR-induced cell contraction ( Figure 5B ). GFP-tagged RhoD is (legend continued on next page) associated with the plasma membrane of vaccinia-induced blebs ( Figure 5C and Movie S5) and can also interact with GST-F11-VK in lysates from infected cells ( Figure S5B ). Furthermore, in vitro pull-down assays with recombinant proteins demonstrate that F11 interacts directly with RhoD ( Figure S5C ). We further examined the impact of expressing siRNA-resistant GFP-tagged wild-type (WT), constitutively active (G26V), or dominant-negative (T31N) RhoD on DF11L-infected cells treated with RhoD siRNA. GFP-tagged RhoD or its constitutively active G26V mutant suppressed the contraction of DF11L-infected cells induced by the depletion of endogenous RhoD ( Figure 5D ). In contrast, GFPRhoD-T31N did not inhibit cell contraction. Taken together, these data suggest that RhoD and RhoC have an antagonistic role during vaccinia-mediated cell contraction. While the presence of RhoC and activity of ROCK are required for F11-induced cell contraction, RhoD must be inactive or absent. Consistent with this, GFP-RhoD-G26V, but not the dominant-negative T31N mutant, suppressed contraction of WR-infected cells ( Figure 5D ). To determine whether RhoD and RhoC are working in the same or parallel pathways, we investigated whether pharmacological inhibition of ROCK, or C3-mediated loss of RhoC signaling, suppresses contraction of DF11L-infected cells that lack RhoD. Indeed, both inhibitors blocked contraction of DF11L-infected cells treated with RhoD siRNA ( Figure 5E ). Furthermore, DF11L-infected cells did not contract in the absence of both RhoC and RhoD, following siRNA silencing of both proteins ( Figure 5F ). Curiously, loss of RhoA, which promotes the spreading of DF11L-infected cells, was partially able to suppress the impact of the loss of RhoD during DF11L infection ( Figure S5D ). Notwithstanding this, taken together our results demonstrate that F11 facilitates RhoC-mediated contraction of WR-infected cells by inhibiting RhoD signaling. Moreover, in non-infected cells expression of dominant-negative GFP-RhoD-T31N increases the level of GTP-bound RhoC, confirming that RhoD can inhibit RhoC activity outside the context of vaccinia infection ( Figure 5G ). Our previous observations demonstrated that RhoA is inactivated by the RhoGAP activity of myosin-9A, which interacts with F11 . It is possible that myosin-9A bound to F11 also inhibits RhoD signaling. However, this does not appear to be the case, as WR still induces contraction of cells treated with myosin-9A siRNA ( Figure S5E ). Furthermore, unlike RhoD siRNA, loss of myosin-9A does not induce contraction of DF11L-infected cells ( Figure S5E ).
RhoD Inhibits RhoC Signaling via Pak6
There are many documented examples and different mechanisms regulating RhoGTPase crosstalk (Guilluy et al., 2011) .
For example, Rac antagonizes RhoA signaling via the p21-activated kinase family members, Pak1 and Pak4, which phosphorylate and inhibit a number of different Rho guanine nucleotide exchange factors (RhoGEFs) to prevent RhoA activation (Barac et al., 2004; Nimnual et al., 2003; Rosenfeldt et al., 2006) . Pak5, a class II family member, is also one of a few known RhoD binding partners (Wu and Frost, 2006) . Given this information, we decided to investigate whether Pak family kinases mediate the antagonistic crosstalk between RhoD and RhoC. We found that pharmacological inhibition of the class I family members Pak1-3 with IPA3 did not stimulate contraction of DF11L-infected cells ( Figure S6A ). In contrast, siRNA-mediated loss of Pak6 but not Pak4 or Pak5 results in cell contraction (Figures 6A, S6B, and S6C) . Furthermore, GFP-tagged Pak6 but not Pak4 or Pak5 associates with the plasma membrane of blebs ( Figure 6B and Movie S6). The DF11L-induced contraction of cells treated with Pak6 siRNA is specific, as it is inhibited by expression of siRNA-resistant GFP-PAK6 ( Figure 6C ). In contrast, the Pak6-K436A kinase-dead mutant did not suppress contraction of DF11L-infected cells treated with Pak6 siRNA ( Figure 6C ). In agreement with this, GFP-PAK6, but not its kinase-dead mutant, blocked WR-induced cell contraction ( Figure 6C ).
To confirm that Pak6 acts upstream of RhoC and ROCK, we examined the impact of inhibiting RhoC or ROCK with C3 and H115, respectively, in DF11L-infected cells depleted of Pak6. In both cases, DF11L-induced contraction of cells lacking Pak6 was suppressed ( Figure 6D ). Cells simultaneously depleted of Pak6 and RhoC also failed to contract ( Figure 6D ). To examine whether Pak6 and RhoD act in the same pathway to inhibit RhoC/ROCK signaling, we expressed GFP-tagged RhoD or Pak6 in cells depleted of endogenous Pak6 or RhoD, respectively. We found that the ability of GFP-RhoD to inhibit contraction of WR-infected cells depends on the presence of Pak6 (Figure 6E) . In contrast, GFP-Pak6 blocks WR-induced contraction in the presence or absence of RhoD ( Figure 6E ). Our data demonstrate that RhoD acts through Pak6 to inhibit RhoC-mediated cell contraction.
RhoD Interacts with Pak6 and Mediates Its Recruitment to the Plasma Membrane
It is thought that RhoGTPases regulate class II Pak kinases by controlling their subcellular location rather than directly stimulating their kinase activity (Ha et al., 2015) . We therefore examined whether RhoD is required to recruit Pak6 to the plasma membrane. We found that there was a dramatic reduction in the association of GFP-Pak6 with the plasma membrane of blebs in DF11L-infected cells treated with RhoD siRNA ( Figure 7A and Movie S7). In contrast, loss of Pak6 had no obvious impact on the recruitment of GFP-RhoD to the plasma membrane (Figure 7A and Movie S7) . These data suggest that RhoD interacts with Pak6 to recruit the kinase to the plasma membrane. Consistent with this, reciprocal pull-downs on myc-and GFP-tagged RhoD and Pak6 demonstrate that the two proteins interact with each other in uninfected cells ( Figure 7B ). Recombinant GST-Pak6 can also retain RhoD but not RhoC or RhoA from cell lysates ( Figures 7C and S7A) . Moreover, pull-down assays with recombinant proteins demonstrate that the interaction between RhoD and Pak6 is direct ( Figures 7D and S7B) . Our data clearly demonstrate that RhoD inhibits RhoC-ROCK-induced cell contraction via its downstream effector Pak6. 
DISCUSSION
The organization and contraction of the cortical actin cytoskeleton plays an essential role in controlling cell shape and movement during development and tumor cell invasion (Blaser et al., 2006; Charras and Paluch, 2008; Fackler and Grosse, 2008; Friedl and Wolf, 2003; Paluch and Raz, 2013; Sahai and Marshall, 2003; Sanz-Moreno et al., 2008; Tozluoglu et al., 2013; Zatulovskiy et al., 2014) . While it is well established that myosin-II drives contraction of the actin cortex, we still lack a complete understanding of the organization and composition of the cortical actin cytoskeleton, as well as the signaling networks controlling its form and function Biro et al., 2013; Bovellan et al., 2014; Fritzsche et al., 2013 Fritzsche et al., , 2016 . One of the hallmarks of myosin-IIdriven contraction of the actin cortex is the formation of blebs at the plasma membrane . Cell blebbing, which occurs during ameboid-based cell motility, mitotic rounding, and cytokinesis (Friedl and Wolf, 2003; Matthews et al., 2012; Sedzinski et al., 2011) , is also frequently seen as part of the so-called cytopathic effect during many different viral infections (Agol, 2012) . In the case of vaccinia virus, cells start to contract and bleb within a few hours of infection (Bablanian et al., 1978; Barry et al., 2015; Schepis et al., 2006; Schramm et al., 2006) . We have now demonstrated that vaccinia-induced cell contraction and blebbing is dependent on the viral protein F11. The ability of F11 to induce ROCK-dependent cell contraction early during viral replication contrasts with its ability to inhibit RhoA signaling in the latter stages of infection (Arakawa et al., 2007b; Cordeiro et al., 2009; Handa et al., 2013; Valderrama et al., 2006) . F11-mediated inhibition of RhoA signaling at 8 hpi stimulates infected cell migration and also facilitates the release of new viral progeny by increasing microtubule growth toward the plasma membrane and modulating the cortical actin cytoskeleton (Arakawa et al., 2007a (Arakawa et al., , 2007b Cordeiro et al., 2009; Handa et al., 2013; Morales et al., 2008; Valderrama et al., 2006) .
Considering the ability of RhoA to bind F11, it was surprising that F11-induced cell contraction depends on RhoC and not RhoA, as both GTPases have been shown to bind and activate ROCK to induce actin stress fiber formation and myosin-II contraction (Leung et al., 1996; Ridley, 2013) . Historically it has been difficult to assign individual effects or cellular responses to RhoA and RhoC, in part because, until relatively recently, most studies tended to focus only on RhoA. Furthermore, expression of constitutively active or dominant-negative RhoA mutants impacts on the activity of both GTPases, as does the inhibitory effect of C3 toxin (Aktories, 2011) . More recently, the use of RNAi-based approaches has begun to uncover distinct functions for RhoA and RhoC (Bravo-Cordero et al., 2011 Korkina et al., 2013; Sahai and Marshall, 2003; Vega et al., 2011) . However, it is striking that the evidence for RhoA driving cell contraction and blebbing is largely based on the use of reagents that do not fully discriminate between RhoA and RhoC (Charras et al., 2006; Costigliola et al., 2010; Gutjahr et al., 2005; Sahai and Marshall, 2003; Sanz-Moreno et al., 2008 ). Our observations demonstrate that RhoC plays the greater role in stimulating ROCK-mediated myosin-II contraction of the actin cortex during vaccinia infection. This conclusion has important implications for a variety of cellular processes involving cell contraction and blebbing that have previously only been assigned to RhoA. It is also striking that there is more evidence suggesting that RhoC is more important than RhoA in promoting tumor cell invasion and metastasis (Clark et al., 2000; Dietrich et al., 2009; Hakem et al., 2005; Kitzing et al., 2010; Leung et al., 1996; Ridley, 2013; Ruth et al., 2006; Sahai and Marshall, 2002; Simpson et al., 2004) .
F11 interacts directly with RhoA using a motif that is similar to that of the Rho-binding site in ROCK Valderrama et al., 2006) . It is likely that F11 will also bind directly to RhoC, as its effector binding switchI/II regions are essentially identical to those in RhoA (Ridley, 2013; Wheeler and Ridley, 2004) . Our in vitro pull-down assays with recombinant protein reveal that RhoC interacts much less efficiently with F11 than with RhoA ( Figure S5C ). The reason for this dramatic difference is not immediately obvious. However, we found that F11 regulates RhoC-mediated cell contraction by inhibiting RhoD signaling. RhoD is emerging as a RhoGTPase family member with diverse functions including regulation of centrosome duplication, cell-cycle progression, actin structures, and membrane trafficking (Gasman et al., 2003; Koizumi et al., 2012; Kyrkou et al., 2013; Nehru et al., 2013) . Previous analysis demonstrates that overexpression of constitutively active RhoD disrupts focal adhesions and stress fibers, and also suppresses the ability of active RhoA to promote actin assembly (Tsubakimoto et al., 1999) . These overexpression data led the authors to suggest that RhoD antagonizes RhoA signaling (Tsubakimoto et al., 1999) . Our data now clearly demonstrate that RhoD antagonizes the function of RhoC, which represents another example of RhoGTPase crosstalk, whereby the action of one GTPase regulates the activity of another. GTPase crosstalk can regulate RhoGEFs and RhoGAPs, GTPase stability, and downstream signaling (reviewed in Guilluy et al., 2011) . One well-documented example of GTPase crosstalk is the inhibition of RhoA by Rac. Following Rac activation, the downstream effectors Pak1 and Pak4 phosphorylate p115-RhoGEF, GEF-H1, PDZ-RhoGEF, and Net1 (Alberts et al., 2005; Barac et al., 2004; Rosenfeldt et al., 2006; Zenke et al., 2004) . Phosphorylation of these RhoGEFs inhibits their exchange activity or alters their stability and/or localization, leading to a loss of downstream RhoA activation. There remains the possibility that Pak1 and Pak4 can also control RhoC-mediated cell contraction, as some of these RhoGEFs also regulate the activity of RhoC (Jaiswal et al., 2011; Ren et al., 1998) . This possibility, together with the observation that RhoD interacts with Pak5 (Wu and Frost, 2006) , led us to investigate whether Pak kinases were involved in vaccinia-induced cell contraction. We found that only depletion of Pak6 stimulated RhoC/ROCK-dependent contraction of DF11L virus-infected cells. Conversely, Pak6 overexpression suppressed contraction of WR-infected cells. Furthermore, RhoD suppressed WR-induced cell contraction through Pak6, suggesting that Pak6 is a RhoD effector. Consistent with this notion, we found that RhoD can interact directly with Pak6 and is responsible for recruitment of the kinase to the plasma membrane.
Our data are in agreement with previous observations suggesting that RhoGTPases principally regulate class II Pak family members by controlling their subcellular location rather than directly stimulating their kinase activity (Ha et al., 2015) . Nevertheless, our results clearly show that the kinase activity of Pak6 is required to inhibit RhoC-induced cell contraction. It is possible that Pak6 may directly phosphorylate RhoC to regulate its activity. Seven of the 22 RhoGTPases, including RhoA, have a serine residue between their phospholipid-binding polybasic region and the CAAX motif that can be phosphorylated (Wheeler and Ridley, 2004) . Phosphorylation of this serine weakens the association of the RhoGTPase with the membrane and also increases its affinity for Rho GDP-dissociation inhibitor (RhoGDI), which extracts the GTPase from membrane (Boulter et al., 2010; Ellerbroek et al., 2003; Garcia-Mata et al., 2011) . However, RhoC does not have an equivalent serine residue between its polybasic region and CAAX motif, so is unlikely to be regulated by this mechanism. Furthermore, our pull-down assays demonstrate that Pak6 does not interact with RhoC. Given this finding it may be that, as with Rac-mediated inhibition of RhoA, Pak6 suppresses the activity of RhoC by phosphorylating one or more RhoGEF. This raises the question of how specificity of a RhoGEF(s) for RhoC over RhoA is achieved. The RhoGEF binding switch I regions of RhoA, B, and C are almost identical, with only a single change for RhoB (Q29E) or RhoC (V43I) (Wheeler and Ridley, 2004) . Structural analysis of RhoA in complex with the LARG, PDZ-RhoGEF, or p63RhoGEF reveals that Val43 participates in van der Waals interactions at the RhoGTPase:GEF interface (Chen et al., 2010; Kristelly et al., 2004; Lutz et al., 2007; Oleksy et al., 2006) . A bulkier isoleucine residue at this point could sterically block the interaction between the RhoGTPase and its GEF. Indeed, the GEF XPLN interacts with RhoA and RhoB but not RhoC, the distinguishing feature being the isoleucine residue at position 43 in RhoC (Arthur et al., 2002; Sloan et al., 2012) . Conversely, it is also conceivable that RhoD/Pak6 can activate a GAP capable of downregulating RhoC signaling. We previously found that RhoA is inactivated by the GAP activity of myosin-9A, in an F11-dependent manner in late stages of infection . However, we now found that in early stages of infection there is no role for myosin-9A, as WR still induces cell contraction and those infected with DF11L remain spread when myosin-9A is depleted ( Figure S5E ). These data also suggest that myosin-9A has no GAP activity toward RhoD.
From our studies it is clear that early during vaccinia infection there must be an additional stimulus activating RhoC, as DF11L virus-infected cells depleted of RhoD or Pak6 contract in an RhoC-dependent fashion. This is consistent with our hypothesis that in DF11L-infected cells RhoD recruits Pak6 to the plasma membrane where it can locally antagonize RhoC signaling to ROCK to inhibit cell contraction. Moreover, the activation of RhoC by an additional viral protein within the first few hours of infection might explain why F11 promotes very different phenotypes at early and late time points during infection. It is also possible that the selectivity of RhoC during vaccinia-induced contraction is actually dependent on this unknown stimulus, leaving the possibility open that Pak6 suppresses both RhoA and RhoC signaling. The task ahead is to understand how vaccinia activates RhoC and to use vaccinia-induced cell contraction as an assay to uncover the basis for Pak6-mediated inhibition of RhoC signaling.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture HeLa cells were cultured in Modified Eagle Medium (MEM) supplemented with 10% SFB, penicillin (100u/ml) and streptomycin (100mg/ml). U-2 OS cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% SFB, penicillin (100u/ml) and streptomycin (100mg/ml). HeLa and U2-OS cells were authenticated by STR profiling and are both negative for mycoplasma.
Viruses and Infections
The wild-type virus used in this work is the Western Reserve strain (WR) (Cudmore et al., 1995) . The recombinant viruses DF11L or F11-VK have been previously described . The virus encoding GFP-F11, with a GGRGG linker between the GFP and N-terminus of F11 was generated by homologous recombination between a targeting vector encoding F12-GFP-F11 and the DF12L virus (Dodding et al., 2009; Zhang et al., 2000; Rietdorf et al., 2001) . The F12-GFP-F11 targeting vector was transfected into HeLa cells 3 hours after infection with the DF12L virus, at a multiplicity of infection of 0.1 plaque-forming units. Two days later, cells were harvested and ruptured by freeze thawing. The cell lysate was then used to infect confluent BSC-1 cell monolayers, which were overlaid with 0.9% agarose 2 h after infection. Four days later, individual plaques were picked based on the rescue of the DF12L small plaque phenotype as well as expression of GFP. The virus in the isolated plaques was then amplified by re-infecting HeLa cells for 48 h. A further 4 rounds of plaque purification were performed until the recombinant GFP-F11 virus was clonal. The fidelity of the recombinant virus was confirmed by sequencing. HeLa or U-2 OS cells were infected with the WR strain of Vaccinia or its
